跳至主要内容
临床试验/EUCTR2016-001772-30-IT
EUCTR2016-001772-30-IT进行中(未招募)1 期

Clinical burden of anemia in inflammatory bowel disease: Role of Iron Deficiency And iron Replacement Therapy, therapeutic trial - NA

FONDAZIONE I.R.C.C.S. POLICLINICO SAN MATTEO0 个研究点目标入组 300 人开始时间: 2021年6月1日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Have given written informed consent to participate
  • Be aged 18 years and over
  • Have IBD and IDA with or without inflammation
  • Have a BMI >16
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 150
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 150

排除标准

  • Patients with hypersensitivity to the IMPs, to other iron containing products and to sucrose or benzil alcohol
  • Pregnancy, lactation and women of childbearing potential (WOCBP) not willing to use highly efficient contraceptive measures
  • history of erythropoietin treatment within 4 weeks prior to recruitment;
  • alcohol abuse, liver cirrhosis, active hepatitis or signs of liver disease with a Child-Pugh class B or C;
  • chronic renal failure stage 4 or higher
  • major surgery in the previous 3 months;
  • significant overt bleeding,
  • acute severe anemia with hemodynamic instability;
  • active malignancy
  • any hematologic disease causing anemia;
  • known active infection;
  • known human immunodeficiency virus, HCV and HBV infections;
  • evidence of tubercular (TB) infection

研究者

发起方
FONDAZIONE I.R.C.C.S. POLICLINICO SAN MATTEO

相似试验